Takeda's office in Denmark: Delta Park Vallensbk Strand
Business Address: Delta Park 45 2665 Vallensbæk Strand
Phone: +45 46 77 10 10
| Native name | 武田薬品工業株式会社 |
|---|---|
| Romanized name | Takeda Yakuhin Kōgyō kabushiki gaisha |
| Formerly | Chobei Takeda & Co., Ltd. (1925-1943) Takeda Pharmaceutical Industries, Ltd. (English name only 1943-1961) Takeda Chemical Industries, Ltd. (English name only 1961-2004) |
| Type | Public KK |
| Traded as | |
| Industry | Pharmaceuticals |
| Founded | Doshomachi, Osaka, Japan (June 12, 1781 (1781-06-12)) |
| Founder | Chobei Takeda I |
| Headquarters | Nihonbashi, Chuo, Tokyo, Japan |
| Key people | Yasuchika Hasegawa (Chairman of the Board) Christophe Weber (President & CEO) |
| Revenue |  ¥1,770,531 million (FY 2018) |
| Operating income |  ¥241,789 million (FY 2018) |
| Net income | ¥186,886 million (FY 2012) |
| Total assets | ¥4,106,463 billion (FY 2018) |
| Total equity | ¥1,997,424 billion (FY 2018) |
| Owner | Nippon Life (2.24%),
BNY Mellon(5.39%) JPMorgan Chase(3.50%) State Street Corporation(1.50%) |
| Number of employees | 49,578 (2019)
(18,378) in United States (5,350) in Japan |
| Website | takeda.com (Global website) |
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in over 230 years of distinguished history in Japan. We have presence in approximately 80 countries, with leading positions in Japan and the U.S., respectively the third and first largest pharmaceutical markets in the world. We will deliver highly innovative medicines and transformative care for more people globally.